Doctor of Pharmacy (2015), Sungkyunkwan University
Poster Finalist, International Society for Pharmacoeconomics and Outcomes Research (ISPOR), 2019
New Venture Competition Grand Award, McGuire Center for Entrepreneurship, 2018
Fulbright Scholar Award, Bureau of Educational and Cultural Affairs of the U.S. Department, 2015-2017
Rho Chi Academic Honor Society in Pharmacy, member, 2017
William/Betty Mileson Fink Fellowship, University of Arizona, 2017
Academic Excellence Award, University of Arizona, 2017
Oh M, AlKhushym N, Fallatah S et al. The Association of BRCA1 and BRCA2 mutations on Prostate Cancer Risk, Frequency, and Mortality: A Meta-Analysis. The Prostate Journal, 2019;79(8):880-895. doi: 10.1002/pros.23795.
Oh M, McBride A, Yun S, et al. Response to Katona et al. Journal of National Cancer Institute, 2019;111(5):524-525. doi: 10.1093/jnci/djz013.
Oh M, McBride A, Yun S, et al. BRCA1 and BRCA2 Gene Mutations and Colorectal Cancer Risk: Systematic Review and Meta-Analysis. Journal of National Cancer Institute, 2018; 110(11):1178-1189. doi: 10.1093/jnci/djy148.
Almutairi A, Alkhatib N, Oh M, et al. Economic Evaluation of Talimogene Laherparepvec Plus Ipilimumab Combination Therapy vs. Ipilimumab Monotherapy in Patients with Advanced Unresectable Melanoma. JAMA Dermatology, 2018; 155(1):22-28. doi: 10.1001/jamadermatol.2018.3958.
Bhattacharjee S, Oh M, Reiman M, et al. Prevalence, Patterns, and Predictors of Depression Treatment among Community-Dwelling Elderly Individuals with Dementia in the United States. American Journal of Geriatric Psychiatry. 2017:25(7):803-813. doi: 10.1016/j.jagp.2017.03.003.
Oh M, McBride A, Yun S, et al. Response to Yang, Shi, Wang et al. Journal of National Cancer Institute, doi.org/10.1093/jnci/djz163